RAPT Therapeutics Inc (RAPT)
4.08
-0.10
(-2.39%)
USD |
NASDAQ |
May 28, 16:00
4.07
-0.01
(-0.25%)
After-Hours: 06:31
RAPT Therapeutics Cash from Investing (Quarterly): 15.89M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.89M |
| December 31, 2023 | 20.64M |
| September 30, 2023 | 25.75M |
| June 30, 2023 | 32.44M |
| March 31, 2023 | 25.31M |
| December 31, 2022 | -41.27M |
| September 30, 2022 | -17.60M |
| June 30, 2022 | -10.46M |
| March 31, 2022 | 23.84M |
| December 31, 2021 | -15.89M |
| September 30, 2021 | -14.17M |
| June 30, 2021 | -63.69M |
| March 31, 2021 | 12.41M |
| Date | Value |
|---|---|
| December 31, 2020 | 15.50M |
| September 30, 2020 | 1.06M |
| June 30, 2020 | -57.01M |
| March 31, 2020 | -46.98M |
| December 31, 2019 | 0.02M |
| September 30, 2019 | -0.076M |
| June 30, 2019 | -0.368M |
| March 31, 2019 | -0.419M |
| December 31, 2018 | -1.654M |
| September 30, 2018 | -0.796M |
| June 30, 2018 | -0.613M |
| March 31, 2018 | -0.437M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-63.69M
Minimum
Jun 2021
32.44M
Maximum
Jun 2023
-4.734M
Average
-0.028M
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | -0.068M |
| Tonix Pharmaceuticals Holding Corp | -0.108M |
| Skye Bioscience Inc | 1.142M |
| Allakos Inc | 9.029M |
| X4 Pharmaceuticals Inc | -5.322M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.08M |
| Cash from Financing (Quarterly) | 9.036M |
| Free Cash Flow | -106.00M |
| Free Cash Flow Per Share (Quarterly) | -0.7039 |
| Free Cash Flow Yield | -67.62% |